RxDoctor Payments Data

Janine Oliver, MD

Urogynecology and Reconstructive Pelvic Surgery · Aurora, CONPI 1003137936

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 90.1% of it on its own, with 3 other manufacturers making up the rest. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in CO, where the typical reported total is $2,505.

$2,213in general payments, 2019–2025

Across 33 payments — averaging $67.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Axonics, Inc.$101
  • Boston Scientific$77
  • AbbVie$42
$355in research payments, 2019–2025

Across 1 payment — averaging $355.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$355

What the payments were for

  • Consulting fees$31514%
  • Travel & lodging$72933%
  • Food & beverage$1,16152%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)28$1,993
Axonics, Inc.1$101
Boston Scientific2$77
AbbVie2$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,213 in reported general payments places this provider in the 45th percentile of 20 urogynecology and reconstructive pelvic surgery providers in Colorado.

See all urogynecology and reconstructive pelvic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$147,556
Medicare patients
242
Services billed
4,379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron63$46,107
GemtesaVibegron24$17,894
Estradiol101$9,711
Methenamine Hippurate30$2,860
Cephalexin30$137
Tamsulosin Hcl20$103
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$59

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →